Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,297,666
+$88,663 QoQ
Shares Held
9,047
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#2,232
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optas, LLC holds $14,428,752 across 12 Drug Manufacturers - General names. JNJ ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,980 | $4,773,731 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
9,047 | $2,297,666 | |
| 3 | ABBV |
AbbVie Inc.
|
7,513 | $1,890,569 | |
| 4 | AZN |
Astrazeneca PLC
|
6,859 | $1,300,603 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,402 | $1,208,156 | |
| 6 | AMGN |
Amgen Inc
|
1,817 | $657,970 | |
| 7 | NVS |
Novartis AG
|
4,098 | $642,237 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,803 | $480,470 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,297,666 | 9,047 | Shares | Other | 2026-07-21 | |
| 2026-03-31 | $2,209,003 | 9,037 | Shares | Other | 2026-04-27 | |
| 2025-12-31 | $1,424,642 | 6,884 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $1,116,227 | 6,020 | Shares | Other | 2025-10-15 | |
| 2025-06-30 | $827,139 | 5,415 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,025,388 | 6,183 | Shares | Other | 2025-04-17 | |
| 2024-12-31 | $705,310 | 4,877 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $936,544 | 5,779 | Shares | Other | 2024-10-29 | |
| 2024-06-30 | $758,130 | 5,187 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,067,148 | 6,746 | Shares | Other | 2024-04-18 | |
| 2023-12-31 | $1,103,761 | 7,042 | Shares | Other | 2024-01-26 | |
| 2023-09-30 | $1,193,822 | 7,665 | Shares | Other | 2023-10-31 | |
| 2023-06-30 | $1,249,343 | 7,548 | Shares | Other | 2023-07-20 | |
| 2023-03-31 | $1,124,680 | 7,256 | Shares | Other | 2023-04-18 | |
| 2022-12-31 | $1,241,141 | 7,026 | Shares | Other | 2023-01-30 | |
| 2022-09-30 | $1,119,178 | 6,851 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $1,187,540 | 6,690 | Shares | Other | 2022-08-01 | |
| 2022-03-31 | $1,221,643 | 6,893 | Shares | Other | 2022-04-26 | |
| 2021-12-31 | $1,197,831 | 7,002 | Shares | Other | 2022-01-26 | |
| 2021-09-30 | $1,126,139 | 6,973 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,143,458 | 6,941 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,084,380 | 6,598 | Shares | Other | 2021-04-19 | |
| 2020-12-31 | $1,447,265 | 9,196 | Shares | Other | 2021-01-27 | |
| 2020-09-30 | $1,773,304 | 11,911 | Shares | Other | 2020-10-23 | |
| 2020-06-30 | $1,093,397 | 7,775 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $506,030 | 3,859 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||